A busy week is set up for the IPO market with
- DouYu International (DOYU) pricing on July 17 and
- Genmab (OTCPK:GMXAY), Assetmark Financial (AMK) Phreesia (PHR), Fulcrum Therapeutics (FULC) and Mirum Pharmaceuticals (MIRM) on July 18.
- Medallia (MDLA) and Afya (AFYA) are also due to price on July 19.
Quiet period expirations arrive on
- Stoke Therapeutics (NASDAQ:STOK), Grocery Outlet (NASDAQ:GO), Personalis (NASDAQ:PSNL), Akero Therapeutics (NASDAQ:AKRO), Atreca (NASDAQ:BCEL) and Prevail Therapeutics (NASDAQ:PRVL) on July 15.
Expect to hear some discussion about Anheuser-Busch InBev (NYSE:BUD) on the likelihood of the beer giant refiling the Budweiser Brewing Company (BUDBC) IPO if market conditions in Hong Kong improve or if the company will move forward with its heavy debt load.
No comments:
Post a Comment